PlainRecalls
FDA Drug Moderate Class II Ongoing

Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%, Net Wt 5.8 g per pre-filled applicator, packaged in 1 prefilled applicator per carton, Rx Only, Manufactured By Padagis, Yeruham, Israel; Distributed By: Padagis, Allegan, MI 49010. NDC: 45802-396-01

Reported: November 8, 2023 Initiated: September 28, 2023 #D-0081-2024

Product Description

Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%, Net Wt 5.8 g per pre-filled applicator, packaged in 1 prefilled applicator per carton, Rx Only, Manufactured By Padagis, Yeruham, Israel; Distributed By: Padagis, Allegan, MI 49010. NDC: 45802-396-01

Reason for Recall

Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing process.

Details

Recalling Firm
Padagis US LLC
Units Affected
10,512 cartons
Distribution
Nationwide within the United States
Location
Minneapolis, MN

Frequently Asked Questions

What product was recalled?
Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%, Net Wt 5.8 g per pre-filled applicator, packaged in 1 prefilled applicator per carton, Rx Only, Manufactured By Padagis, Yeruham, Israel; Distributed By: Padagis, Allegan, MI 49010. NDC: 45802-396-01. Recalled by Padagis US LLC. Units affected: 10,512 cartons.
Why was this product recalled?
Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing process.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 8, 2023. Severity: Moderate. Recall number: D-0081-2024.